Mark J. Ratain to Cytochrome P-450 CYP2D6 Inhibitors
This is a "connection" page, showing publications Mark J. Ratain has written about Cytochrome P-450 CYP2D6 Inhibitors.
Connection Strength
0.040
-
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy. Clin Pharmacol Ther. 2018 05; 103(5):770-777.
Score: 0.040
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.